Clinical Trials in Minneapolis

Showing 2741-2760 of 12,418 trials

Maternal Stress, Milk Composition, and Preterm Neurodevelopment

NCT05537454

This study explores the associations between maternal stress, breastmilk composition, and feeding and neurodevelopment for preterm infants in the NICU and at 4 months corrected age.

Prematurity

University of Minnesota120 participantsStarted Dec 2022

Minneapolis, Minnesota, United States

COMPLETEDPhase 1/2< 1 mile

Study of an Live-Attenuated Respiratory Syncytial Virus Vaccine in Infants and Toddlers

NCT04491877

The primary objectives of the study were: * To assess the safety profile of each dose of the study product after each and any administration in all infants and toddlers regardless of baseline serostatus. * To characterize the Respiratory Syncytial Virus (RSV) A serum neutralizing antibody responses to the study product in each vaccine group after vaccination in RSV-naïve participants. The secondary objectives of the study were: * To quantify the amount of vaccine virus shed by each participant by baseline serostatus. * To determine the proportion of vaccinated infants and toddlers in each vaccine group infected with the vaccine virus at D56 (56 days after vaccination 1) for Cohorts 1, 2, 3 and 4, and at Day 84 (28 days after vaccination 2) for Cohorts 2 and 4 by baseline serostatus. * To characterize the RSV A serum neutralizing antibody responses to the study product in each vaccine group after vaccination in RSV-experienced participants. * To characterize serum RSV anti-F immunoglobulin G (IgG) antibody responses to the study product in each vaccine group after vaccination by baseline serostatus. * To characterize serum RSV antibody responses (RSV A-neutralizing and anti-RSV F IgG) to the study product in each vaccine group after the RSV surveillance season or at least 5 months after the last vaccine administration by baseline serostatus.

Respiratory Syncytial Virus Infection

Sanofi Pasteur, a Sanofi Company259 participantsStarted Sep 2020

Gardena, California, United States • La Mesa, California, United States • Los Angeles, California, United States +26 more locations

Maternal Stress, Milk Composition, and Preterm Neurodevelopment

Study of an Live-Attenuated Respiratory Syncytial Virus Vaccine in Infants and Toddlers

Find Trials by Condition in Minneapolis

S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis

OCS DCD Heart + CAP Continued Follow-Up

PNOC 001: Phase II Study of Everolimus for Recurrent or Progressive Low-grade Gliomas in Children

ACHIEVE Hearing Intervention Follow-Up Study

A Study of Relatlimab Plus Nivolumab Versus Nivolumab Alone in Participants With Advanced Melanoma

Abatacept in Immune Checkpoint Inhibitor Myocarditis

A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression

Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer

Evaluation of Rifaximin SSD for Delaying Encephalopathy Decompensation in Patients With Cirrhosis

A Safety/Tolerability and PK Study With Azstarys® in Children With ADHD

Burden of Recreational Water Illness Due to Exposure to Cyanobacteria and Their Toxins in Freshwater Beaches in Canada

A Prospective, US-based Study Assessing Mogamulizumab-associated Rash in Patients Diagnosed With Mycosis Fungoides or Sezary Syndrome and Treated With Standard of Care Mogamulizumab

First-in-Human Study of OKI-219 in Advanced Solid Tumors and Advanced Breast Cancer

Phase 2a Study of the Safety, Tolerability, and Pharmacokinetics of Topically Administered PRN473 (SAR444727) in Patients With Mild to Moderate Atopic Dermatitis

Efficacy and Safety of Tolebrutinib (SAR442168) Tablets in Adult Participants With Generalized Myasthenia Gravis

PLAN Intervention to Enhance Engagement of Latino Cancer Patients in Advanced Care Planning

Safety and Tolerability of Carboxyamidotriazole Orotate (CTO) in Solid Tumors or With Temodar® in Glioblastoma or Other Recurrent Malignant Gliomas or in Combination With Temodar® and Radiation Therapy for Patients With Newly Diagnosed Glioblastoma and Malignant Gliomas

Skin Reactions Related to Thoracic Implantable Chamber Dressings